Home › Funds › Renaissance Technologies › ALKS
Renaissance Technologies position in ALKS
ALKERMES PLC · Health Care
Renaissance Technologies reported holding 6,493,828 shares of ALKS (ALKERMES PLC) in its Q3 2026 13F filing — a position valued at US$263.1M, representing 0.36% of its reported portfolio and ranking #39 among its reported holdings. Renaissance Technologies has disclosed ALKS holdings in 45 of the last 55 reported quarters, going back to Q1 2013.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Renaissance Technologies's ALKS position evolved
Renaissance Technologies first disclosed a stake in ALKS in Q1 2013 at 117,800 shares (US$2.8M). The position peaked in Q2 2026 at 6,460,928 shares, worth US$338.5M. Across 45 filings, Renaissance Technologies increased the stake 24 time(s), trimmed it 16 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 6,493,828 shares valued at US$263.1M — an increase of 32,900 shares quarter over quarter.. Notable position changes include a 575% increase in Q2 2013, a 303% increase in Q2 2014, a 211% increase in Q1 2015.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2013 | 117.80K | $2.79M | New |
| Q2 2013 | 794.69K | $22.79M | Add |
| Q3 2013 | 661.69K | $22.25M | Reduce |
| Q4 2013 | 505.59K | $20.56M | Reduce |
| Q1 2014 | 53.31K | $2.35M | Reduce |
| Q2 2014 | 214.69K | $10.80M | Add |
| Q3 2014 | 155.79K | $6.68M | Reduce |
| Q4 2014 | 63.99K | $3.75M | Reduce |
| Q1 2015 | 198.69K | $12.11M | Add |
| Q2 2015 | 229.29K | $14.75M | Add |
| Q4 2015 | 26.29K | $2.09M | New |
| Q1 2017 | 124.89K | $7.31M | New |
| Q1 2018 | 114.79K | $6.65M | New |
| Q4 2018 | 794.40K | $23.44M | New |
| Q1 2019 | 1.65M | $60.13M | Add |
| Q2 2019 | 3.95M | $89.05M | Add |
| Q3 2019 | 4.90M | $95.62M | Add |
| Q4 2019 | 6.64M | $135.39M | Add |
| Q1 2020 | 7.18M | $103.55M | Add |
| Q2 2020 | 7.14M | $138.46M | Reduce |
| Q3 2020 | 6.78M | $112.41M | Reduce |
| Q4 2020 | 6.96M | $138.76M | Add |
| Q1 2021 | 6.07M | $113.30M | Reduce |
| Q2 2021 | 5.28M | $129.43M | Reduce |
| Q3 2021 | 4.74M | $146.32M | Reduce |
| Q4 2021 | 4.81M | $111.90M | Add |
| Q1 2022 | 4.87M | $128.08M | Add |
| Q2 2022 | 5.32M | $158.56M | Add |
| Q3 2022 | 5.56M | $124.07M | Add |
| Q4 2022 | 5.64M | $147.49M | Add |
| Q1 2023 | 4.94M | $139.23M | Reduce |
| Q2 2023 | 5.17M | $161.71M | Add |
| Q3 2023 | 6.12M | $171.31M | Add |
| Q4 2023 | 6.05M | $167.81M | Reduce |
| Q1 2024 | 5.89M | $159.37M | Reduce |
| Q2 2024 | 5.48M | $132.16M | Reduce |
| Q3 2024 | 5.42M | $151.73M | Reduce |
| Q4 2024 | 5.48M | $157.57M | Add |
| Q1 2025 | 5.74M | $189.50M | Add |
| Q2 2025 | 5.81M | $166.23M | Add |
| Q3 2025 | 6.29M | $188.78M | Add |
| Q4 2025 | 6.67M | $186.57M | Add |
| Q1 2026 | 6.16M | $217.83M | Reduce |
| Q2 2026 | 6.46M | $338.52M | Add |
| Q3 2026 | 6.49M | $263.13M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ALKS and 13F data
ALKS (ALKERMES PLC) is a Health Care company. 37 other funds we track also report a position in ALKS — the largest reported positions include BAKER BROS. ADVISORS LP (US$524.6M), Deep Track Capital, LP (US$209.6M), Commodore Capital LP (US$157.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ALKS
- BAKER BROS. ADVISORS LP 10.01M sh · $524.59M · Q2 2026
- Deep Track Capital, LP 4.00M sh · $209.58M · Q2 2026
- Commodore Capital LP 3.00M sh · $157.19M · Q2 2026
- BVF INC/IL 2.15M sh · $112.90M · Q2 2026
- Bain Capital Life Sciences Investors, LLC 1.94M sh · $101.54M · Q2 2026
- RTW INVESTMENTS, LP 1.67M sh · $87.62M · Q2 2026
- Soleus Capital Management, L.P. 1.03M sh · $53.93M · Q2 2026
More on Renaissance Technologies
FAQ
How long has Renaissance Technologies held ALKS?
Renaissance Technologies has disclosed ALKS holdings in 45 of the last 55 reported quarters, going back to Q1 2013.
What is Renaissance Technologies's current position in ALKS?
As of Q3 2026, Renaissance Technologies holds 6.49M shares of ALKS (ALKERMES PLC), valued at $263.13M, representing 0.36% of its reported portfolio and ranking #39.
Has Renaissance Technologies been buying or selling ALKS?
In the latest 13F filing (Q3 2026), Renaissance Technologies increased its position in ALKS. The position peaked in Q2 2026 at 6.46M shares.
Which other funds hold ALKS?
Other major institutional holders of ALKS include BAKER BROS. ADVISORS LP, Deep Track Capital, LP, Commodore Capital LP, among 37 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.